Press release
Anti-Hypertensive Drugs Market Analysis and Forecast up to 2030
Can Anti-hypertensive Drugs Worsen Condition of COVID-19 Patients?Anti-hypertensive drugs are under scrutiny for reducing the symptoms of COVID-19 (coronavirus). However, in many research journals, it has been found that these drugs carry the potential risk of increasing the abundance of SARS-CoV-2 receptors, which is the virus that causes coronavirus.
As such, these claims are being argued by Carlos Ferrario, a professor of general surgery at the Wake Forest School of Medicine. Increased media coverage for boosting the levels of angiotensin-converting-enzyme (ACE) inhibitors in anti-hypertensive drugs has prompted many patients to call their doctor for consultations.
Get Brochure of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1791
Medical associations such as the American College of Cardiology and the European Society of Cardiology have suggested consumption of anti-hypertensive drugs due to a lack of evidence to support ACE inhibitors. Companies in the anti-hypertensive drugs market are maintaining steady supply chains since COVID-19 is closely related to the respiratory system of hypertension patients.
Thiazide Diuretics, Chlorthalidone, or Hydrochlorothiazide: Which is Better for Reducing Mortality Rates?
Anti-hypertensive drugs are being publicized for reduced fatal outcomes and improved clinical characteristics in elderly COVID-19 patients. It has been found that dyspnea and fatigue were significantly improved in COVID-19 patients with the help of calcium-channel blockers (CCB) and thiazide diuretics. Companies in the anti-hypertensive drugs market are increasing their output capabilities in thiazide diuretics, as they are the first line of treatment for hypertension. Thiazide-type diuretics, chlorthalidone, and indapamide have demonstrated to be superior in both treatment and cost efficiency.
Get Table of Content of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=1791
Thiazide diuretics are emerging as an alternative to hydrochlorothiazide, as the former is better at decreasing the risk of cardiovascular diseases. Companies in the anti-hypertensive drugs market are manufacturing chlorthalidone for patients who opt for mono-therapy. This drug is boosting market growth, as it controls blood pressure and prevents morbidity and mortality. Chlorthalidone is a close alternative to hydrochlorothiazide, since the former decreases systolic blood pressure.
Oral Medications Help Overcome Limitations of Transcutaneous Drug Delivery
Hypertension is one of the most significant medical conditions in a large population globally. However, low oral availability of drugs is hampering the growth of the anti-hypertensive drugs market. Despite the large armamentarium of drugs for high blood pressure management, there is a growing need for alternative drug delivery systems. As such, the transcutaneous delivery of drugs is emerging as a potential alternative for efficient management of high blood pressure.
Read Report Overview @ https://www.transparencymarketresearch.com/anti-hypertensive-drugs.html
Transcutaneous delivery of anti-hypertensive drugs is found to improve clinical outcomes. However, possible challenges such as skin irritation and limited iontophoretic transport of medications through micro-needles are inhibiting the growth of the anti-hypertensive drugs market. Hence, pharma companies are increasing their R&D in oral medications to overcome limitations of transcutaneous drug delivery.
Combination Therapy Addresses Inadequacies in Mono-therapy in High Risk Patients
If a patient fails to respond to mono-therapy, combination therapy can be preferred for efficient high blood pressure management. In order to meet patient needs, companies in the anti-hypertensive drugs market are producing ACE inhibitors and calcium-channel blockers. As such, a combination of angiotensin II receptor blockers (ARBs) and thiazide diuretics is found to significantly improve patient quality of life. It has been discovered that the combination of benazepril-amlodipine is superior to benazepril-hydrochlorothiazide combination, since the former helps to reduce cardiovascular events in patients with high risk.
Benazepril-amlodipine combination is gaining increased popularity for decreasing the progression of nephropathy in high-risk patients. Companies in the anti-hypertensive drugs market are diversifying their production activities in loop diuretics, alpha blockers, hydralazine, and minoxidil, among others, to capitalize on business opportunities.
Get Custom Research Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=1791
Companies Divest Rights to Manufacturers to Focus on New Medicine Portfolios
The loss of patent protection for anti-hypertensive drugs has compelled companies in the healthcare industry to adopt alternative business strategies. For instance, AstraZeneca- a science-led biopharmaceutical company, has agreed to sell its commercial right to Atnahs Pharma (Atnahs) for its Inderal (propranolol), Tenormin (atenolol), and Zestril (lisinopril) drugs to focus on the pipeline of new medicines. Manufacturers in the anti-hypertensive drugs market are increasing efforts to retain their commercial rights in the U.S., India, and Japan, since these countries are projected for exponential growth during the forecast period.
Companies in the anti-hypertensive drugs market are shifting their focus from non-core mature brands to investments in new medicine portfolios in order to gain a competitive advantage over other market players. As such, tenormin (atenolol) is being highly publicized for lowering the risk of death after a heart attack. There is a growing demand for drugs that cater to congestive heart failure and hypertensive renal disease.
Contact
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com
About Us
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Anti-Hypertensive Drugs Market Analysis and Forecast up to 2030 here
News-ID: 2780135 • Views: …
More Releases from Transparency Market Research

Global Solar Powered Agricultural Dryer Market to Exceed USD 2.4 Billion by 2031 …
The global solar powered agricultural dryer market, valued at US$ 1.6 billion in 2022, is projected to grow at a CAGR of 5.8% from 2023 to 2031, reaching US$ 2.4 billion by the end of 2031. Rising investments in renewable energy, growing awareness of sustainable agricultural practices, and the rapid expansion of the agricultural sector driven by population growth are key factors fueling market growth.
Uncover essential discoveries and trends from…

Technetium-99m Market Forecast 2034: Rising Demand for Diagnostic Imaging and Ra …
The global Technetium‐99m Market was valued at US$ 6.0 Billion in 2023 and is projected to grow at a CAGR of 3.3% from 2024 to 2034, surpassing US$ 8.6 Billion by the end of the forecast period. Advancements in nuclear imaging infrastructure, government-backed healthcare initiatives, and an increasing demand for precise diagnostic procedures are fueling this growth.
Discover essential conclusions and data from our Report in this sample -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=77100
Analysts' Viewpoint
The Technetium‐99m…

Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to …
The global Equine Diagnostic Services Market, valued at approximately US$ 168 million in 2019, is projected to expand at a compound annual growth rate (CAGR) of ~5% from 2020 to 2030, reaching around US$ 280 million by 2030. Equine diagnostic services, encompassing tests like genetic, infectious disease, and imaging diagnostics, are critical for managing horse health in veterinary hospitals, clinics, and mobile settings. The market is driven by increasing equine…

Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of …
The digital printing market is experiencing strong growth, driven by rapid technological advancements, rising demand for personalized and on-demand printing, and an increasing focus on sustainable solutions. Digital printing allows for the direct transfer of digital files onto a wide range of substrates, offering high-resolution output with greater speed and flexibility. Its adaptability has led to broad adoption across industries such as packaging, textiles, publishing, and advertising-sectors where customization, efficiency,…
More Releases for Companies
saudi arabia construction company,engineering consultant companies in saudi arab …
AK Group
Al Judee Holding
Al Shatii Projects Contracting Co
Al Suroor United Group
Al Yamama Company
Alesayi Development Company (ADCO)
Alfanar
Almeer Saudi Technical Services Co
Alrabiah Consultants And Engineers
Alshalawi holding
Arabian Consulting Engineering Centre (ACEC)
Asas Dar
Assad Said for Contracting Co Ltd
Battoyor Holding Company
https://gzwatches.cn/
Free engineering construction consultation
Email: nolan@toolcabinetrolling.com
Bechtel
Bin Dayel Contracting
Construction Technical Services Arabia (CTSA)
Contracting Construction Enterprises
Dar Al Riyadh
ETE Buildings & Engineering
East Consulting Engineering Center
El Seif Engineering Contracting Company
FCC Company
JNCO
Masar Consulting Engineer
Nesma Partners
RAM Contracting
STFA Investment Holding Group
Saipem
Salini Impregilo S.P.A
Saudi…
List of engineering companies in UAE, List of Engineering Contracting companies …
ABU Hussain Co LLC
ACCL International
AE 7 LLC
AECOM
AL Faisaliyah Contracting LLC
AL Reyami Group
AL Rostamani Group Of Companies
ALEC
https://szwatches.cn/
Free engineering construction consultation
Email:nolan@wholsale9.com
ALSA Engineering & Construction Company
AMB Hertel
ANC Holdings LLC
Abu Dhabi Construction Company (ADCC)
Afreen Building Materials Trading Co LLC
Al Ahd General Contracting LLC - AGCM
Al Ahli Holding Group
Al Asab General Transport & Contracting Establishment
Al Fara'a General Contracting
Al Futtaim Carillion
Al Hussain General Contracting
Al Marwan Group Holding
Al Naboodah Construction Group LLC
Al Nasr Contracting Company L.L.C
Al Rakha…
List of China's top engineering companies, list of China's engineering consultin …
1. China National Nuclear Corporation Limited
2. China Aerospace Science and Technology Corporation Limited
https://african-digest.com/
Free engineering consultation
Email:nolan@wholsale9.com
3. China Aerospace Science and Industry Corporation Limited
4. Aviation Industry Corporation of China LTD
5. China State Shipbuilding Corporation Limited
6. China North Industries Group Co., LTD
7. China Ordnance Equipment Group Co. LTD
8. China Electronics Technology Group Co., LTD
9. Aero Engine Group Corporation of China LTD
10. China Rongtong Asset Management Group Co. LTD
11. China National Petroleum Corporation Limited
12.…
List of China engineering companies, list of European engineering companies, lis …
ACS ACTIVIDADES DE CONSTRUCCIÓN Y SERVICIOS SA, Madrid, Spain†
HOCHTIEF AG, Essen, Germany†
https://oberlodropship.com/
Free engineering consultation
Email:nolan@wholsale9.com
VINCI, Rueil-Malmaison, France†
CHINA COMMUNICATIONS CONSTRUCTION GROUP LTD., Beijing, China†
BOUYGUES, Paris, France†
STRABAG SE, Vienna, Austria†
POWER CONSTRUCTION CORP. OF CHINA, Beijing, China†
SKANSKA AB, Stockholm, Sweden†
CHINA STATE CONSTRUCTION ENGINEERING CORP. LTD., Beijing, China†
FERROVIAL, Madrid, Spain†
CHINA RAILWAY CONSTRUCTION CORP. LTD., Beijing, China†
FLUOR, Irving, Texas, U.S.A.†
CHINA RAILWAY GROUP LTD., Beijing, China†
SAIPEM SPA, San Donato Milanese, Italy†
EIFFAGE, Velizy-Villacoublay, France†
HYUNDAI ENGINEERING & CONSTRUCTION CO.…
US Residential Construction Companies Database (49,000 companies)
We are delighted to announce the addition of the US Residential Construction Companies Database to our catalogue, containing nearly 50,000 residential construction companies in the United States.
US Residential Construction Companies Database (49,000 companies) is an Excel spreadsheet containing a list of the largest Residential Construction Companies in the United States. The combined list includes the largest residential construction companies within each of 49 states. This database contains the leading companies…
Saudi Arabia Pharmaceutical Market | pharmaceutical companies in saudi arabia, p …
In order to study the various trends and patterns prevailing in the concerned market, Market Research Reports Search Engine (MRRSE) has included a new report titled “Saudi Arabia Pharmaceutical Market” to its wide online database. This research assessment offers a clear insight about the influential factors that are expected to transform the global market in the near future.
The report examines Saudi Arabia pharmaceutical market for the period 2016–2026. The primary…